Characteristics and outcomes from COVID-19 among Peruvian physicians: a nationwide register-based study.

The healthcare workforce has played an integral role in fighting COVID-19 and continues to do so despite the continuous adverse outcomes. To address this issue, official public data concerning COVID-19 cases and deaths of Peruvian physicians was used to quantify the risk of death and infection by SARS-CoV-2. 20.

Hydroxychloroquine / azithromycin in COVID-19: The association between time to treatment and case fatality rate.

Background: Currently, there is no formally accepted pharmacological treatment for COVID-19.

Materials And Methods: We included COVID-19 outpatients of a Peruvian primary care center from Lima, Peru, who were treated between April 30 - September 30, 2020, with hydroxychloroquine and azithromycin. Logistic regression was applied to determine factors associated with case-fatality rate.